Elliot Maltz
Directeur Financier/CFO chez ALIMERA SCIENCES, INC.
Fortune : 271 $ au 31/12/2023
Postes actifs de Elliot Maltz
Sociétés | Poste | Début | Fin |
---|---|---|---|
ALIMERA SCIENCES, INC. | Directeur Financier/CFO | 02/01/2024 | - |
Treasurer | 02/01/2024 | - |
Historique de carrière de Elliot Maltz
Anciens postes connus de Elliot Maltz
Sociétés | Poste | Début | Fin |
---|---|---|---|
ORGENESIS INC. | Directeur Financier/CFO | 01/09/2023 | 31/12/2023 |
Secrétaire Général | 01/09/2023 | 31/12/2023 | |
Treasurer | 01/09/2023 | 31/12/2023 | |
GELESIS HOLDINGS, INC. | Comptroller/Controller/Auditor | 13/01/2022 | 15/08/2023 |
Compliance Officer | 01/10/2022 | 15/08/2023 | |
Directeur Financier/CFO | 13/01/2022 | 15/08/2023 | |
Secrétaire Général | 01/10/2022 | 15/08/2023 | |
Treasurer | 13/01/2022 | 15/08/2023 | |
GELESIS INC | Directeur Financier/CFO | 01/05/2021 | 01/01/2022 |
Treasurer | 01/05/2015 | 01/01/2022 | |
SAPIENT CORPORATION | Comptroller/Controller/Auditor | 01/04/2013 | 01/03/2014 |
Deloitte & Touche LLP
Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Comptroller/Controller/Auditor | 01/01/2007 | 01/04/2013 |
Formation de Elliot Maltz
Elon University | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 8 |
Opérationnelle
Director of Finance/CFO | 4 |
Treasurer | 4 |
Comptroller/Controller/Auditor | 3 |
Sectorielle
Health Technology | 5 |
Commercial Services | 3 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 3 |
---|---|
GELESIS HOLDINGS, INC. | Health Technology |
ORGENESIS INC. | Health Technology |
ALIMERA SCIENCES, INC. | Health Technology |
Entreprise privées | 3 |
---|---|
Gelesis, Inc.
Gelesis, Inc. BiotechnologyHealth Technology Gelesis, Inc. operates as a consumer-centered biotherapeutics company, which engages in the development of novel therapies to induce weight loss and metabolic disorders. Its commercial product portfolio includes Plenity, an FDA-cleared product to aid in weight management, as well as potential therapies in development for patients with Type 2 Diabetes, Non-alcoholic Fatty Liver Disease /Non-alcoholic Steatohepatitis, and Functional Constipation. The company was founded by Yishai Zohar in 2006 and is headquartered in Boston, MA. | Health Technology |
Sapient Corp.
Sapient Corp. Miscellaneous Commercial ServicesCommercial Services Sapient Corp. provides consultancy and interactive marketing services. The company was founded by James Stuart Moore and Jerry A. Greenberg in 1990 and is headquartered in Boston, MA. | Commercial Services |
Deloitte & Touche LLP
Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Commercial Services |
- Bourse
- Insiders
- Elliot Maltz
- Expérience